Quantum BioPharma Ltd.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-05-18
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital
News release - English.pdf
Results 2026-05-07
Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026
News release - English.pdf
Results 2026-05-06
Interim MD&A - English.pdf
Results 2026-05-06
Interim financial statements/report – English.pdf
Ownership 2026-04-07
Carroll, Donal sold +$763k
Insider trading – 2026-04-07
1 insider · −$763k net
News 2026-04-02
Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied
News release - English.pdf
News 2026-04-01
Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis
News release - English.pdf
Transactions 2026-03-31 Financing
Report of exempt distribution (45-106F1).pdf
News 2026-03-30
Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
News release - English.pdf
Results 2026-03-27
Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status
News release - English.pdf
Results 2026-03-26 Financials
Annual report on form 20-F - English.pdf
Results 2026-03-26 Financials
Annual report - English.pdf
Results 2026-03-26 Financials
Annual MD&A - English.pdf
Results 2026-03-26 Financials
Audited annual financial statements – English.pdf
Transactions 2026-03-25 Financing
Quantum BioPharma Ltd. Announces Closing of Initial Tranche of Private Placement and Debt Settlement
Material change report - English.pdf
News 2026-03-23
Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd
News release - English.pdf
Transactions 2026-03-20 Financing
Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering
News release - English.pdf
Transactions 2026-03-12 Financing
Quantum BioPharma Provides Corporate Update
News release - English.pdf
Transactions 2026-03-11 Financing
Quantum BioPharma Provides Corporate Update
News release - English.pdf
Results 2025-12-23
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)
News release - English.pdf
News 2025-12-22
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
News release - English.pdf
News 2025-12-19
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
News release - English.pdf
News 2025-12-11
Early warning report.pdf
News 2025-12-11
Early warning report.pdf
Transactions 2025-12-11 Financing
QUANTUM BIOPHARMA ANNOUNCES CLOSING OF PRIVATE PLACEMENT & PROVIDES CORPORATE UPDATE
News release - English.pdf
News 2025-12-01
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC
News release - English.pdf
News 2025-11-27
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) Announces Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC
News release - English.pdf
News 2025-11-26
Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
News release - English.pdf
News 2025-11-25
Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
News release - English.pdf
News 2025-11-07
News release - English.pdf
Results 2025-11-06 Financials
Interim MD&A - English.pdf
Results 2025-11-06 Financials
Interim financial statements/report – English.pdf
News 2025-11-01
Other.pdf
News 2025-11-01
News release - English.pdf
News 2025-10-30
Early warning report.pdf
News 2025-10-30
Material change report - English.pdf
News 2025-10-30
News release - English.pdf
News 2025-10-23
News release - English.pdf
News 2025-10-20
News release - English.pdf
News 2025-10-17
Notice Form 45-102F1.pdf
News 2025-10-14
News release - English.pdf
News 2025-10-08
News release - English.pdf
News 2025-10-03
News release - English.pdf
News 2025-10-02
News release - English.pdf
News 2025-10-01
News release - English.pdf
News 2025-09-30
Material change report - English.pdf
News 2025-09-29
News release - English.pdf
News 2025-09-29
News release - English.pdf
News 2025-09-24
News release - English.pdf
News 2025-09-18
News release - English.pdf
News 2025-09-12
News release - English.pdf
News 2025-09-10
News release - English.pdf
News 2025-08-27
Other.pdf
News 2025-08-27
Other.pdf
News 2025-08-27
Other.pdf
News 2025-08-21
News release - English.pdf
News 2025-08-12
News release - English.pdf
News 2025-08-11
News release - English.pdf
News 2025-08-08
News release - English.pdf
News 2025-08-07
News release - English.pdf
Results 2025-08-06 Financials
Interim financial statements/report – English.pdf
Results 2025-08-06 Financials
Interim MD&A - English.pdf
Results 2025-08-06 Financials
Interim financial statements/report – English.pdf
News 2025-08-05
News release - English.pdf
News 2025-08-04
News release - English.pdf
News 2025-07-31
News release - English.pdf
News 2025-07-22
News release - English.pdf
News 2025-07-08
News release - English.pdf
News 2025-06-27
News release - English.pdf
News 2025-06-27
Material change report - English.pdf
News 2025-06-26
News release - English.pdf
News 2025-06-17
News release - English.pdf
News 2025-06-13
News release - English.pdf
News 2025-06-10
News release - English.pdf
News 2025-06-03
News release - English.pdf